Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?

Liver cancer(2022)

Cited 4|Views44
No score
Abstract
SULF2 derived from CAFs modulates glypican-3/β-catenin signalling but also the HCC immune TME, associated with tumour progression and therapy resistance via activation of the TAK1/IKKβ/NF-κB pathway. It is an attractive target for combination therapies for patients with HCC.
More
Translated text
Key words
Biomarkers,Glypican-3,Hepatocellular carcinoma,Inflammation,Metabolic disease,Molecular targets,NASH,Spheroids,Sulfatase-2,Tumour microenvironment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined